Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Smallpox Vaccine”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT01827371
What this trial is testing

Phase II Trial to Assess Safety and Immunogenicity of IMVAMUNE®

Who this might be right for
Smallpox
National Institute of Allergy and Infectious Diseases (NIAID) 435
Testing effectiveness (Phase 2)Study completedNCT00316602
What this trial is testing

A Phase II Study on Immunogenicity and Safety of MVA-BN® (IMVAMUNE™) Smallpox Vaccine in Subjects With Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
Bavarian Nordic 632
Large-scale testing (Phase 3)Study completedNCT00607243
What this trial is testing

Safety and Efficacy of CJ-50300 in Healthy Volunteers

Who this might be right for
Smallpox
Seoul National University Hospital 123
Early research (Phase 1)Ended earlyNCT00282581
What this trial is testing

Safety Study of MVA Smallpox Vaccine in HIV-positive Subjects Who Are Vaccinia Naive

Who this might be right for
HIV InfectionsSmallpox
Sanofi Pasteur, a Sanofi Company 2
Not applicableStudy completedNCT03745131
What this trial is testing

Cohort Study of Healthcare Workers Receiving Imvanex®

Who this might be right for
Monkeypox
Public Health England 120
Testing effectiveness (Phase 2)Study completedNCT00914732
What this trial is testing

Lyophilized IMVAMUNE® (1x10^8 TCID50) Versus Liquid IMVAMUNE® (1x10^8 TCID50) Administered Subcutaneously and a Lower Dose Liquid IMVAMUNE® (2x10^7 TCID50) Administered Intradermally

Who this might be right for
Smallpox
National Institute of Allergy and Infectious Diseases (NIAID) 523
Not applicableStudy completedNCT00325975
What this trial is testing

Immune Responses to Smallpox Vaccination

Who this might be right for
Smallpox Vaccine
National Institute of Allergy and Infectious Diseases (NIAID) 69
Large-scale testing (Phase 3)Study completedNCT05846243
What this trial is testing

Study on Immunogenicity, Reactogenicity and Safety of the VACΔ6 Vaccine in Volunteers Aged 18-60 Years

Who this might be right for
SmallpoxMonkeypoxCowpox+1 more
Federal Budgetary Research Institution State Research Center of Virology and Biotechnology "Vector" 334
Testing effectiveness (Phase 2)Active Not RecruitingNCT04957485
What this trial is testing

Study to Assess the Safety and Immunogenicity of TPOXX® When Administered Orally for 28 Days With JYNNEOS

Who this might be right for
Smallpox
SIGA Technologies 100
Early research (Phase 1)Study completedNCT00336635
What this trial is testing

Safety and Immunogenicity of CJ-50300

Who this might be right for
Smallpox
Seoul National University Hospital 24
Not applicableStudy completedNCT00998543
What this trial is testing

A Long-Term Study of Healthy Adults Vaccinated With One Dose of Smallpox Vaccine (LISTER Strain)

Who this might be right for
Smallpox
Sanofi 147
Testing effectiveness (Phase 2)Study completedNCT00032708
What this trial is testing

Dryvax Dilution-Prev Vacc Adults

Who this might be right for
Smallpox
National Institute of Allergy and Infectious Diseases (NIAID) 90
Large-scale testing (Phase 3)Study completedNCT02977715
What this trial is testing

JYNNEOS Smallpox Vaccine in Adult Healthcare Personnel at Risk for Mpox in the Democratic Republic of the Congo

Who this might be right for
Monkeypox Virus Infection
Centers for Disease Control and Prevention 1,600
Early research (Phase 1)Study completedNCT00053742
What this trial is testing

Phase I/II Trial of Modified Vaccinia Virus Ankara (MVA) Vaccine Against Smallpox

Who this might be right for
Healthy
National Institute of Allergy and Infectious Diseases (NIAID) 80
Post-approval studies (Phase 4)Study completedNCT02443623
What this trial is testing

VA-008 ACAM2000® Vaccination of Plasma Donors for the Production of VIGIV

Who this might be right for
Smallpox Vaccine Adverse Reaction
Emergent BioSolutions 3,032
Early research (Phase 1)Study completedNCT00189969
What this trial is testing

Take Rate, Immunogenicity and Safety of Elstree-BN Smallpox Vaccine in Healthy Vaccinia-Naive Subjects

Who this might be right for
Smallpox
Bavarian Nordic 50
Large-scale testing (Phase 3)Study completedNCT01913353
What this trial is testing

A Non-inferiority Trial to Compare MVA-BN® Smallpox Vaccine to ACAM2000®

Who this might be right for
18-42 Year Old Healthy Vaccinia-naïve Subjects
Bavarian Nordic 440
Early research (Phase 1)WithdrawnNCT00006630
What this trial is testing

Vaccinia Immune Globulin in Treating or Preventing Vaccinal Infection

Who this might be right for
HealthyCommunicable Diseases
National Institute of Allergy and Infectious Diseases (NIAID)
Testing effectiveness (Phase 2)Study completedNCT00879762
What this trial is testing

High Dose IMVAMUNE® in Vaccinia-Naive Individuals

Who this might be right for
Smallpox
National Institute of Allergy and Infectious Diseases (NIAID) 91
Large-scale testing (Phase 3)Study completedNCT03699124
What this trial is testing

Freeze-Dried MVA-BN® Lot Consistency Smallpox Trial

Who this might be right for
Smallpox
Bavarian Nordic 1,129
Next Page